Drug Information

Drug General Information
Drug ID
D0A7GW
Former ID
DNC010173
Drug Name
N-(piperidin-4-yl)-N-propyl-2-naphthamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530367]
Structure
Download
2D MOL

3D MOL
Formula
C19H24N2O
Canonical SMILES
CCCN(C1CCNCC1)C(=O)C2=CC3=CC=CC=C3C=C2
InChI
1S/C19H24N2O/c1-2-13-21(18-9-11-20-12-10-18)19(22)17-8-7-15-5-3-4-6-16(15)14-17/h3-8,14,18,20H,2,9-13H2,1H3
InChIKey
KPOGSLKDEJXGPM-UHFFFAOYSA-N
PubChem Compound ID
45487772
Target and Pathway
Target(s) Sodium-dependent serotonin transporter Target Info Inhibitor [530367]
Potassium voltage-gated channel subfamily H member 2 Target Info Inhibitor [530367]
KEGG Pathway Serotonergic synapse
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway 5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathway
PathWhiz Pathway Muscle/Heart Contraction
Reactome Voltage gated Potassium channels
WikiPathways Monoamine Transport
SIDS Susceptibility Pathways
NRF2 pathway
Synaptic Vesicle Pathway
Serotonin Transporter ActivityWP706:SIDS Susceptibility Pathways
Hematopoietic Stem Cell Differentiation
Potassium Channels
References
Ref 530367Bioorg Med Chem Lett. 2009 Oct 15;19(20):5893-7. Epub 2009 Aug 21.Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
Ref 530367Bioorg Med Chem Lett. 2009 Oct 15;19(20):5893-7. Epub 2009 Aug 21.Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.